Медикаментозна підготовка пацієнтів до хірургічної реваскуляризації міокарда

І.В. Шклянка, О.Й. Жарінов, О.А. Єпанчінцева, Б.М. Тодуров

Література  

1. Shklianka IV, Zharinov OJ, Mikhaliev КO, Yepanchintseva OA. Clinical characteristics and usage of statins in patients with stable ischemic heart disease referred for angiography or coronary artery bypass grafting. Cardiac Surgery and Interventional Cardiology. 2017;4:20–30 (in Ukr.).
2. Shklianka IV, Zharinov OJ, Mikhaliev КO, Yepanchintseva OA, Todurov BM. Predictors of early complications after coronary artery bypass grafting in patients with stable coronary heart disease. Ukr. Cardiol. J. 2018;6:32–44. doi: 10.31928/1608-635X-2018.6.3446. (in Ukr.).
3. Airaksinen KE, Biancari F, Karjalainen P. et al. Safety of coronary artery bypass surgery during therapeutic oral anticoagulation. Thromb Res. 2011;128(5):435–439. doi: 10.1016/j.thromres.2011.05.021.
4. Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg. 2007;22:247–256.
5. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ. 2002;324:71–86.
6. Barakat AF, Saad M, Abuzaid A. et al. Perioperative statin therapy for patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2016;101(2):818–825.
7. Biancari F, Myllylä M, Lepojärvi S. et al. Preoperative warfarin treatment and outcome of coronary artery bypass graft surgery. Ann Thorac Surg. 2010;89(4):1139–1145. doi: 10.1016/j.athoracsur.2009.12.072.
8. Burger W, Chemnitius JM, Kneissl GD. et al. Low-dose aspirin for secondary cardiovascular prevention — cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation review a meta-analysis. J Intern Med. 2005;257:399–414.
9. Bybee KA, Powell BD, Valeti U. et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005;112:I286–I292.
10. Cao C, Indraratna P, Ang SC. et al. Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2014;148 (6):3092–3098. doi: 10.1016/j.jtcvs.2014.04.054.
11. Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiology. 2013;36, N 8:1017–1023. doi.org/10.1111/pace.12140.
12. Chu MWA, Wilson SR, Novick RJ. et al. Does clopidogrel increased blood loss following coronary artery bypass surgery. Ann Thorac Surg . 2004;78:1536–1541.
13. Collard CD, Body SC, Shernan SK, Wang S, Mangano DT. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2006;132:392–400. doi: 10.1016/j.jtcvs.2006.04.009.
14. Dacey LJ, Munoz JJ, Johnson ER. et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg. 2000;70:1986–1990.
15. Devereaux PJ, Mrkobrada M, Sessler DI. et al. Aspirin in patients undergoing noncardiac surgery. New Engl J Med. 2014;370 (16):1494–1503.
16. Douketis J, Gregory YH. Lip. Perioperative management of patients receiving anticoagulants. UpToDate. 2019.
17. Goodnough LT, Smith PK, Levy JH. et al. Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. J Thorac Cardiovasc Surg. 2013;145:1077–1082. doi: 10.1016/j.jtcvs.2012.07.059.
18. Hansson EC, Jidéus L, Åberg B. et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016;37 (2):189–197. doi: 10.1093/eurheartj/ehv381.
19. Hassan K, Bayer N, Oberhoffer M. et al. Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2018;105 (Issue 3):702–708. doi: 10.1016/j.athoracsur.2017.11.066.
20. Holm M, Biancari F, Khodabandeh S. et al. Bleeding in patients treated with ticagrelor or clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2019;107 (6):1690–1698. doi: 10.1016/j.athoracsur.2019.01.086.
21. Kairevicute D, Aidietis A, Gregory YH. Atrial fibrillation following cardiac surgery: clinical features and preventive strategies. Eur Heart J. 2009;30:410–425.
22. Kallis P, Tooze JA, Talbot S. et al. Preoperative aspirin decreases platelet aggregation and increases postoperative blood loss: a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg. 1994;8 (8):404–409.
23. Klein M, Keith PR, Dauben HP. et al. Aprotinin counterbalances an increased risk of perioperative hemorrhage in CABG patients pretreated with aspirin. Eur J Cardiothorac Surg. 1998;14:360–366.
24. Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2019. pii:ehz425. doi: 10.1093/eurheartj/ehz425.
25. Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews. 2015;8. CD008493 doi: 10.1002/14651858.CD008493.pub3.
26. Kulik A, Ruel M, Jneid H. et al. Secondary prevention after coronary artery bypass graft surgery //A Scientific Statement from the American Heart Association. Circulation. 2015;131 (10):927–964. doi: 10.1161/CIR.0000000000000182.
27. Landoni G, Casso G, Gallo M. et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Critісаl Care. 2016;20:395.
28. Lewis HD. Jr, Davis JW, Archibald DG. et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. New Engl J Med. 1983;309 (7):396–403.
29. Liakopoulos OJ, Choi YH, Haldenwang PL. et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008;29 (12):1548–1559. doi: 10.1093/eurheartj/ehn198.
30. Liakopoulos OJ, Kuhn EW, Hellmich M. et al.; StaRT-CABG Investigators. Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial. Am Heart. J. 2015;170(1):46–54. doi: 10.1016/j.ahj.2015.04.015.
31. MacCallum NS, Finney SJ, Gordon SE. et al. Modified criteria for the systemic inflammatory response syndrome (SIRS) improves their utility following cardiac surgery. Chest. 2014;145:1197–1203. doi: 10.1378/chest.13-1023.
32. Mitchell LB, Exner DV, Wyse DG. et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: A randomized controlled trial. JAMA. 2005;294:3093–3100.
33. Moshiri E, Dadashpoor N, Golestani-Eraghi M. et al. Prophylactic effect of amiodarone in atrial fibrillation after coronary artery bypass surgery; a double-blind randomized controlled clinical trail. J Cardiovasc Disease Research. 2015;6. Р.12–17. DOI:10.5530/jcdr.2015.1.2.
34. Myles PS, Smith JA, Forbes A. et al, on behalf of the ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery. New Engl J Med. 2016. doi: 10.1056/NEJMoa1606424.
35. Neumann F–J, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40 (Issue 2):87–165. doi: 10.1093/eurheartj/ehy394.
36. Onk OA, Erkut B. Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery? Medicine (Baltimore). 2015;94(41):e1576. doi:10.1097/MD.0000000000001576.
37. Ozaydin M, Dogan A, Varol E. et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007;107:117–121.
38. Pan W, Collard CD, Coselli J. et al. Effect of dose and timing of preoperative statins on mortality after coronary artery bypass surgery. The Annals of Thoracic Surgery. 2017 Mar 15. pii: S0003-4975(17)30016-4. doi: 10.1016/j.athoracsur.2016.12.043.
39. Patrono C, Baigent C, Hirsh J. et al. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133:199S–233S. doi: 10.1378/chest.08-0672.
40. Patti G, Chello M, Candura D. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3. Circulation. 2006;114:145–1461.
41. Price MJ, Walder JS, Baker BA. et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: The recovery trial. J Am Coll Cardiol. 2012;59:2338–2343.
42. Sadeghpour A, Khamooshi AJ, Rezaei M, Askari B. Does clopidogrel increase blood loss following coronary artery bypass surgery? Iran. J. Cardiac. Surgery. 2011;3(2):25–29.
43. Serebruany VL, Malinin AI, Eisert RM, Sane DC. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol. 2004;75:40–47.
44. Serruys PW, Morice MC, Kappetein AP. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New Engl J Med. 2009;360:961–972. doi: 10.1053/j.ajkd.2009.09.007.
45. Song Gu, Su Pi-Xiong, Yan Liu et al. Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years. Chinese Med J. 2009;122:2928–2932.
46. Sousa-Uva М, Head SJ, Milojevic М. et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardio-Thoracic Surgery. 2018;53:5–33. doi: 10.1093/ejcts/ezx314.
47. Steffel J, Verhamme P, Potpara TS. et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39 (Iss. 16):1330–1393. doi: 10.1093/eurheartj/ehy136.
48. Sun JC, Whitlock R, Cheng J. et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J. 2008;29:1057–1071. doi: 10.1093/eurheartj/ehn104.
49. Tandon V, Bano G, Khajuria V. et al. Pleiotropic effects of statins. Ind J Pharmacology. 2005;37. № 2:77–85.
50. Warren OJ, Smith AJ, Alexiou C. et al. The inflammatory response to cardiopulmonary bypass: part 1 – mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23:223–231.
51. Weng OwK, Thomas M, Parker W. et al. 72 Offset of ticagrelor prior to coronary artery bypass graft surgery (cabg) surgery. Heart. 2017;103:A53–A54.
52. WHO Model Lists of Essential Medicines. ADULTS – 19th ed. (April 2015) Rev. November 2015.
53. Zheng Z, Jayaram R, Jiang L. et al. Perioperative rosuvastatin in cardiac surgery. New Engl J Med. 2016;374:1744–1753. doi: 10.1056/NEJMc1608082.